{"nct_id":"NCT04699461","title":"Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma","status":"TERMINATED","status_verified_date":"2023-09","start_date":"2021-11-04","start_date_type":"ACTUAL","primary_completion_date":"2022-11-25","primary_completion_date_type":"ACTUAL","completion_date":"2022-11-25","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ADCT"]}